Raymond James Trust N.A. Reduces Stake in HCA Healthcare, Inc. (NYSE:HCA)

Raymond James Trust N.A. decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.6% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,918 shares of the company’s stock after selling 90 shares during the quarter. Raymond James Trust N.A.’s holdings in HCA Healthcare were worth $6,063,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Darsana Capital Partners LP boosted its holdings in shares of HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares in the last quarter. TD Asset Management Inc increased its position in shares of HCA Healthcare by 2.7% during the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock worth $238,110,000 after purchasing an additional 19,812 shares in the last quarter. Epoch Investment Partners Inc. increased its stake in HCA Healthcare by 16.4% during the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after purchasing an additional 88,948 shares in the last quarter. National Pension Service grew its holdings in shares of HCA Healthcare by 11.9% during the third quarter. National Pension Service now owns 550,654 shares of the company’s stock valued at $223,802,000 after buying an additional 58,353 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in HCA Healthcare by 2.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 520,835 shares of the company’s stock worth $167,426,000 after acquiring an additional 11,861 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent research reports. Truist Financial upped their target price on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday. UBS Group upped their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, KeyCorp decreased their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Six research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $324.92 on Friday. The stock has a market capitalization of $82.30 billion, a price-to-earnings ratio of 14.59, a price-to-earnings-growth ratio of 1.28 and a beta of 1.68. HCA Healthcare, Inc. has a 52 week low of $245.84 and a 52 week high of $417.14. The firm has a 50-day simple moving average of $379.40 and a 200-day simple moving average of $358.05. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 in the last three months. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.